MedPath
TGA Approval

CELLRENEWAL (399613)

399613

CELLRENEWAL

Aussia Pharma

November 17, 2022

Medicine

Medicine

Active

Listed

Active Ingredients

Citrus bioflavonoids extract

folic acid

leucine

nicotinamide

nicotinic acid

resveratrol

Reynoutria japonica

Vitis vinifera

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CELLRENEWAL (399613) - TGA 批准文号 | MedPath